Singapore markets open in 3 hours 17 minutes
Straits Times Index
3,286.33 +15.35 (+0.47%) S&P 500
4,210.24 +87.77 (+2.13%) Dow
33,309.51 +535.11 (+1.63%) Nasdaq
12,854.80 +360.88 (+2.89%) BTC-USD
23,951.39 +756.12 (+3.26%) CMC Crypto 200
559.85 +28.63 (+5.39%)
Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 8.13 |
| Open | 8.30 |
| Bid | 8.17 x 3100 |
| Ask | 8.50 x 900 |
| Day's range | 8.12 - 8.57 |
| 52-week range | 7.70 - 33.97 |
| Volume | |
| Avg. volume | 2,852,453 |
| Market cap | 1.206B |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.26 |
| Earnings date | 01 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.31 |
- Motley Fool
Why Aurinia Pharmaceuticals Stock Briefly Spiked Today
Shares of commercial-stage autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) raced higher in early action Thursday morning, rising as much as 15.7%. Why did investors bid up Aurinia's shares?
- Zacks
Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
VICTORIA, British Columbia, August 04, 2022--Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
© 2022 Yahoo. All rights reserved.
